Outsourced Pharma Capacity Update Videos - Small Molecule
-
AbbVie Capacity Update October 2024: Small Molecule
10/23/2024
Watch this overview of our extensive capabilities, including a deep dive into our HPAPI and API services and the available capacity at our Campoverdi, Italy facility for your next project.
-
Douglas CDMO Capacity Update July 2024: Small Molecule Finished Dosage Form
8/14/2024
We specialize in high-potency softgels and liquids and have deep experience producing prescription drugs for classifications including oncology, dermatology, the central nervous system and immunity.
-
Alcami Capacity Update July 2024: Small Molecule Finished Dosage Form
8/14/2024
Alcami boasts a state-of-the-art OSD development suite that includes manufacturing equipment, non-GMP analytical testing lab, stability chambers, and small scale blistering equipment.
-
AustinPx Capacity Update July 2024: Small Molecule Finished Dosage Form
8/14/2024
Our client-centric approach is designed to simplify the complexity of outsourcing and our team of formulation, analytical and manufacturing experts work with you to overcome challenges.
-
Curia Capacity Update July 2024: Small Molecule APl And HPAPI Development
8/14/2024
Learn about Curia’s industry-leading practices in critical disciplines such as high-potency compounds, commercialization of products with our customers, and our growing expertise in chromatography.
-
AbbVie Capacity Update July 2024: Small Molecule APl And HPAPI Development
8/14/2024
Review a detailed examination of our HPAPI & API capabilities, with a particular focus on our Campoverdi, Italy facility which currently has capacity available for near-term projects.
-
MilliporeSigma Capacity Update May 2024: Small Molecule APl and HPAPI Development
6/12/2024
Our small molecule API CDMO team has the expertise, experience, and specialized facilities to make our customers' small molecule API projects a success.
-
Capacity Update May 2024: Small Molecule APl And HPAPI Development
6/12/2024
With 37 cGMP mills of different sizes and types, and dedicated areas for steroids, HPAPIs, and even cryogenic milling, our Monteggio site is well-equipped to support a wide range of customer projects.
-
Ajinomoto Bio-Pharma Services Capacity Update May 2024: Small Molecule APl and HPAPI Development
6/12/2024
Our experts delve into the advancements in our development and manufacturing capabilities for HPAPI, clinical development, and late stage projects.
-
Adare Pharma Solutions Capacity Update May 2024: Small Molecule APl and HPAPI Development
6/12/2024
An outsourcing partner with services from the earliest phases of development and formulation to manufacturing and packaging is critical for advancing your product to market with reduced cost and time.